Mårten Fernö

Researcher
More filtering options
  1. 2019
  2. 2018
  3. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

    Carina Forsare, Bak, M., Falck, A. K., Grabau, D., Killander, F., Per Malmström, Lisa Rydén, Stål, O., Sundqvist, M., Pär Ola Bendahl & Mårten Fernö, 2018 Dec 7, In : BMC Cancer. 18, 1, 1226.

    Research output: Contribution to journalArticle

  4. Immune gene expression and response to chemotherapy in advanced breast cancer

    Foukakis, T., Lövrot, J., Matikas, A., Zerdes, I., Lorent, J., Tobin, N., Suzuki, C., Brage, S. E., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Mårten Fernö, Skoog, L., Bergh, J., Hatschek, T. & TEX Study Group, 2018 Feb 20, In : British Journal of Cancer. 118, 4, p. 480-488

    Research output: Contribution to journalArticle

  5. Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial

    Siker Kimbung, Markholm, I., Bjöhle, J., Lekberg, T., Wachenfeldt, V. A., Azavedo, E., Saracco, A., Hellström, M., Srinivas Veerla, Paquet, E., Pär Ola Bendahl, Mårten Fernö, Bergh, J., Niklas Loman, Hatschek, T. & Ingrid Hedenfalk, 2018, In : International Journal of Cancer. 142, 3, p. 618-628

    Research output: Contribution to journalArticle

  6. Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

    Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Per Malmström, Carina Forsare, Mårten Fernö, Schmid, T., Brüne, B. & Jung, M., 2018, In : OncoImmunology. 7, 3, e1408751.

    Research output: Contribution to journalArticle

  7. 2017
  8. PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients

    Tobin, N. P., Lundberg, A., Lindström, L. S., Harrell, J. C., Foukakis, T., Carlsson, L., Einbeigi, Z., Linderholm, B. K., Niklas Loman, Malmberg, M., Mårten Fernö, Czene, K., Perou, C. M., Bergh, J., Hatschek, T. & TEX Trialists Group, 2017 Dec 1, In : Clinical Cancer Research. 23, 23, p. 7225-7231 7 p.

    Research output: Contribution to journalArticle

  9. Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial

    Martin Sjöström, Lundstedt, D., Linda Hartman, Holmberg, E., Killander, F., Kovács, A., Per Malmström, Emma Niméus, Rönnerman, E. W., Mårten Fernö & Karlsson, P., 2017 Oct 1, In : Journal of Clinical Oncology. 35, 28, p. 3222-3229 8 p.

    Research output: Contribution to journalArticle

  10. Quality of up to 35 years old archival breast cancer tissue in paraffinblocks for estrogen receptor evaluation

    Anna Ehinger, Lisa Rydén, Pär-Ola Bendahl, Mårten Fernö & Alkner, S., 2017 Sep 2, In : Virchows Archiv. 471, Suppl. 1, p. 54 1 p., PS-01-016.

    Research output: Contribution to journalPublished meeting abstract

  11. 2016
  12. 2015
  13. Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.

    Siker Kimbung, Kovács, A., Danielsson, A., Pär-Ola Bendahl, Lövgren, K., Stolt, M. F., Tobin, N. P., Lindström, L., Bergh, J., Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2015, In : Oncotarget. 6, 32, p. 33306-33318

    Research output: Contribution to journalArticle

  14. Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.

    Maria Ekholm, Grabau, D., Pär-Ola Bendahl, Bergh, J., Elmberger, G., Olsson, H., Russo, L., Viale, G. & Mårten Fernö, 2015, In : Acta Oncologica. 54, 7, p. 1040-1048

    Research output: Contribution to journalArticle

  15. Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.

    Busch, S., Sims, A. H., Stal, O., Mårten Fernö & Landberg, G., 2015, In : Cancer Research. 75, 7, p. 1457-1469

    Research output: Contribution to journalArticle

  16. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

    Tobin, N. P., Harrell, J. C., Lovrot, J., Egyhazi Brage, S., Frostvik Stolt, M., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Walz, T., Mårten Fernö, Perou, C. M., Bergh, J., Hatschek, T. & Lindstrom, L. S., 2015, In : Annals of Oncology. 26, 1, p. 81-88

    Research output: Contribution to journalArticle

  17. 2014
  18. 32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.

    Siker Kimbung, Kovács, A., Johansson, I., Danielsson, A., Pär-Ola Bendahl, Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i11-i12

    Research output: Contribution to journalArticle

  19. A novel model for Ki67 assessment in breast cancer.

    Quinci Romero, Pär-Ola Bendahl, Mårten Fernö, Grabau, D. & Signe Borgquist, 2014, In : Diagnostic Pathology. 9, 1, 118.

    Research output: Contribution to journalArticle

  20. 2013
  21. Grading breast cancer tissues using molecular portraits.

    Olsson, N., Skoog, P., Peter James, Hansson, K. M., Waldemarson, S., Per Malmström, Mårten Fernö, Lisa Rydén, Christer Wingren & Carl Borrebaeck, 2013, In : Molecular & Cellular Proteomics. 12, 12, p. 3612-3623

    Research output: Contribution to journalArticle

  22. Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial

    Bjohle, J., Bergqvist, J., Gronowitz, J. S., Johansson, H., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Söderberg, M., Sundquist, M., Walz, T. M., Mårten Fernö, Bergh, J. & Hatschek, T., 2013, In : Breast Cancer Research and Treatment. 139, 3, p. 751-758

    Research output: Contribution to journalArticle

  23. The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.

    Klintman, M., Carina Forsare, Ahlin, C., Beglerbegovic, S., Fjällskog, M-L., Grabau, D., Gudlaugsson, E., Janssen, E. A. M., Lövgren, K., Skaland, I., Pär-Ola Bendahl, Per Malmström, Baak, J. P. A. & Mårten Fernö, 2013, In : PLoS ONE. 8, 12, e81902.

    Research output: Contribution to journalArticle

  24. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  25. 2012
  26. A Molecular Taxonomy for Urothelial Carcinoma.

    Gottfrid Sjödahl, Martin Lauss, Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Oliver Hultman Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér, Wiking Månsson, Fredrik Liedberg, David Lindgren & Mattias Höglund, 2012, In : Clinical Cancer Research. 18, 12, p. 3377-3386

    Research output: Contribution to journalArticle

  27. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

    Falck, A-K., Pär-Ola Bendahl, Christian Ingvar, Isola, J., Jönsson, P-E., Lindblom, P., Lövgren, K., Rennstam, K., Mårten Fernö & Lisa Rydén, 2012, In : BMC Cancer. 12

    Research output: Contribution to journalArticle

  28. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.

    Karolina Holm, Grabau, D., Lövgren, K., Aradottir, S., Sofia Gruvberger, Jillian Howlin, Lao Saal, Ethier, S. P., Pär-Ola Bendahl, Stål, O., Per Malmström, Mårten Fernö, Lisa Rydén, Cecilia Hegardt, Åke Borg & Markus Ringnér, 2012, In : Molecular Oncology. 6, 5, p. 494-506

    Research output: Contribution to journalArticle

  29. Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

    Hatschek, T., Carlsson, L., Einbeigi, Z., Lidbrink, E., Linderholm, B., Lindh, B., Niklas Loman, Malmberg, M., Rotstein, S., Soderberg, M., Sundquist, M., Walz, T. M., Hellstrom, M., Svensson, H., Astrom, G., Brandberg, Y., Carstensen, J., Mårten Fernö & Bergh, J., 2012, In : Breast Cancer Research and Treatment. 131, 3, p. 939-947

    Research output: Contribution to journalArticle

  30. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.

    Jönsson, G. B., Staaf, J., Vallon-Christersson, J., Ringnér, M., Gruvberger, S., Saal, L., Holm, K., Hegardt, C., Arason, A., Fagerholm, R., Olsson, C., Grabau, D., Johnsson, E., Lövgren, K., Magnusson, L., Heikkilä, P., Agnarsson, B. A., Johannsson, O. T., Malmström, P., Fernö, M. & 5 othersHåkan Olsson, Niklas Loman, Nevanlinna, H., Barkardottir, R. B. & Åke Borg, 2012, In : Cancer Research. 72, 16, p. 4028-4036

    Research output: Contribution to journalArticle

  31. 2011
  32. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

    Carlsson, M., Cederfur, C., Schaar, V., Balog, C. I. A., Lepur, A., Touret, F., Salomonsson, E., Deelder, A. M., Mårten Fernö, Håkan Olsson, Wuhrer, M. & Hakon Leffler, 2011, In : PLoS ONE. 6, 10, e26560.

    Research output: Contribution to journalArticle

  33. Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

    Carlsson, A., Christer Wingren, Nordström, M., Carsten Rose, Mårten Fernö, Håkan Olsson, Jernstöm, H., Sara Ek, Gustavsson, E., Christian Ingvar, Mattias Ohlsson, Peterson, C. & Carl Borrebaeck, 2011, In : Proceedings of the National Academy of Sciences. 108, 34, p. 14252-14257

    Research output: Contribution to journalArticle

  34. 2010
  35. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  36. Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.

    Klintman, M., Ornbjerg Würtz, S., Christensen, I., Bræmer Hertel, P., Mårten Fernö, Malmberg, M., Mouridsen, H., Cold, F., Schrohl, A-S., Foekens, J., Per Malmström & Brünner, N., 2010, In : Breast Cancer Research and Treatment. 121, p. 365-371

    Research output: Contribution to journalArticle

  37. Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis

    Carina Forsare, AhlinGullers, A., Fjallskog, M. L., Malmstrom, P. & Mårten Fernö, 2010, In : EJC Supplements. 8, 3, p. 95-96

    Research output: Contribution to journalPublished meeting abstract

  38. Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

    Emma Niméus, Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R-M., Karin Jirström, Wärnberg, F., Blomqvist, C., Mårten Fernö & Fjällskog, M-L., 2010, In : International Journal of Cancer. 127, p. 961-967

    Research output: Contribution to journalArticle